IBB Doesn't Fit The Mantra Of High-Risk High-Reward - iShares Nasdaq Biotechnology ETF (NASDAQ:IBB) | Seeking Alpha
This is a great article about IBB, a biotech ETF which has beaten the market in bull and bear times. The author showed a great chart about how IBB performed better than the market in 2008. In fact, IBB should have been considered the canary in the coal mine during the last bear market. It was actually positive for a while when the major indexes were negative. Then, when IBB finally went negative, that should have been a major bear market sign and a sure time to rush to the sidelines.
Subscribe to:
Post Comments (Atom)
No comments:
Post a Comment